Andrew Zloza
- Immunology top 2%
- Immunotherapy and Immune Responses 23
- Immune Cell Function and Interaction 18
- T-cell and B-cell Immunology 12
- Oncology top 2%
- CAR-T cell therapy research 22
- Cancer Immunotherapy and Biomarkers 14
- Genetics top 1%
- Virus-based gene therapy research 19
- Biotechnology top 2%
- Cancer Research and Treatments 8
- Virology top 5%
-
- RNA Interference and Gene Delivery 5
- Co-authors
- Howard L. KaufmanFrederick J. KohlhappPraveen K. BommareddyDavid M. AboulafiaP RubinsteinSamuel D. RabkinJason M. SchenkelErica Huelsmann
- Cited by
- ImmunologyOncologyGenetics
- Journals
- Journal of Clinical Investigation (1 paper)Nature Medicine (2 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Andrew Zloza
78 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Immunology 1.3k
- Oncology 1.6k
- Genetics 1.3k
- Biotechnology 323
- Virology 145
Countries citing papers authored by Andrew Zloza
This map shows the geographic impact of Andrew Zloza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Zloza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Zloza more than expected).
Fields of papers citing papers by Andrew Zloza
This network shows the impact of papers produced by Andrew Zloza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Zloza. The network helps show where Andrew Zloza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Zloza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 8 | |
| 7 | 2020 | 9 | |
| 8 | 2019 | 97 | |
| 9 | ONC201 IN COMBINATION WITH RADIATION EXHIBITS SYNERGISTIC EFFICACY IN HIGH GRADE GLIOMAS AND OTHER ADVANCED CANCERS | 2018 | 1 |
| 10 | 2018 | 30 | |
| 11 | 2017 | 14 | |
| 12 | 2017 | 130 | |
| 13 | 2016 | 101 | |
| 14 | 2015 | 3 | |
| 15 | 2014 | 7 | |
| 16 | 2014 | 6 | |
| 17 | 2014 | 19 | |
| 18 | 2013 | 70 | |
| 19 | 2011 | 1 | |
| 20 | 2010 | 13 |
About Andrew Zloza
Andrew Zloza is a scholar working on Immunology, Oncology and Biotechnology, having authored 83 papers that have together received 3.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (23 papers), CAR-T cell therapy research (22 papers), Virus-based gene therapy research (19 papers), Immune Cell Function and Interaction (18 papers), Cancer Immunotherapy and Biomarkers (14 papers), T-cell and B-cell Immunology (12 papers), Cancer Research and Treatments (8 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (1.6k citations) and Genetics (1.3k citations). Andrew Zloza has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Howard L. Kaufman, Frederick J. Kohlhapp, Praveen K. Bommareddy, David M. Aboulafia, P Rubinstein, Samuel D. Rabkin, Jason M. Schenkel, Erica Huelsmann, Charles B. Chesson and Lena Al‐Harthi. Their work appears in journals such as Journal of Clinical Investigation, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.